603235 天新药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.94612.41214.71911.47920.853
总资产报酬率 ROA (%)2.36310.03312.1809.74116.302
投入资产回报率 ROIC (%)2.70911.68214.21511.24519.443

边际利润分析
销售毛利率 (%)39.99242.31242.01138.27237.225
营业利润率 (%)27.63830.07735.06129.87431.486
息税前利润/营业总收入 (%)29.28128.96029.96124.58827.560
净利润/营业总收入 (%)22.97825.22729.48625.28526.992

收益指标分析
经营活动净收益/利润总额(%)93.03695.16495.15192.31391.246
价值变动净收益/利润总额(%)0.9751.2670.9960.3671.511
营业外收支净额/利润总额(%)-0.040-0.127-0.3350.5220.009

偿债能力分析
流动比率 (X)5.0814.3785.2876.76610.175
速动比率 (X)4.0953.4824.1315.7288.663
资产负债率 (%)19.04120.57017.62216.84113.290
带息债务/全部投入资本 (%)2.1891.600-3.915-5.832-6.832
股东权益/带息债务 (%)4,196.8035,754.929-2,462.095-1,659.567-1,452.416
股东权益/负债合计 (%)425.173386.153467.476493.804652.428
利息保障倍数 (X)17.706-26.848-6.012-4.518-7.013

营运能力分析
应收账款周转天数 (天)42.67044.72942.09746.59346.227
存货周转天数 (天)130.328154.228150.130147.134109.004